Skip to main content

Table 5 The features of operation and postoperative complications in patients with APGC

From: Risk evaluation of splenic hilar or splenic artery lymph node metastasis and survival analysis for patients with proximal gastric cancer after curative gastrectomy: a retrospective study

 

NSR (n = 572)

CR (n = 152)

SPR (n = 113)

P

Operation time (min)

192 ± 13

241 ± 21

221 ± 7

< 0.001a

Intraoperativetransfusion

154 (26.9%)

68 (44.7%)

36 (31.8%)

< 0.001b

Postoperativehospital stay (days)

12.63 ± 1.45

15.25 ± 2.86

12.86 ± 1.68

< 0.001a

Examined lymph nodes

25.11 ± 13.71

28.38 ± 14.47

27.02 ± 11.32

0.018a

Non-lethal Complication

48 (8.4%)

34 (22.4%)

14 (12.4%)

< 0.001b

Anastomotic leakage

14

7

3

 

Pancreas-related complications

6

10

0

 

Lung pleura- related complications

7

6

2

 

Wound complication

5

2

3

 

Postoperative ileus

13

6

5

 

Liver dysfunction

3

3

0

 

Mortality*

3

9

1

NS

Postoperative chemotherapy

   

0.118

Presence

406(69.4%)

96(16.4%)

83(14.2%)

 

Absence

166(65.9%)

56(22.2%)

30(11.9%)

 
  1. NSR: Nosplenic hilar orsplenic arteryLN resection;APGC: Advanced proximal gastric cancer
  2. a: one-way anova,b:χ2test; *:these patients had excluded from the study